Carman Alenson, Principal Accounting Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 472 shares at $47.12 ($22K) on 2020-02-26, disclosed to the SEC on 2020-02-28.
Scheduled sale ($22k) by Principal Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2021-04-16 | $54K | — | Filing → |
| AGIO | SELL | 2020-09-04 | $10K | — | Filing → |
| AGIO | SELL | 2020-03-04 | $16K | — | Filing → |